Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
09/19/2001 | EP1134214A1 Picolinamide derivatives and pest controllers containing the same as the active ingredient |
09/19/2001 | EP1134213A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides |
09/19/2001 | EP1133493A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
09/19/2001 | EP1133489A1 Isonipecotamides for the treatment of integrin-mediated disorders |
09/19/2001 | EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors |
09/19/2001 | EP1133483A1 Il-5 inhibiting 6-azauracil derivatives |
09/19/2001 | EP1133482A1 Il-5 inhibiting 6-azauracil derivatives |
09/19/2001 | EP1133294A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
09/19/2001 | EP1133293A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
09/19/2001 | EP0869954B1 Heterocyclic compounds for use in the treatment of neurogenic inflammation |
09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
09/19/2001 | CN1313853A Oxindole derivatives as growth hormone releasers |
09/19/2001 | CN1313280A Benzheterocyclic derivatives |
09/19/2001 | CN1071333C Quinoline derivative |
09/19/2001 | CN1071327C Denzothiazine dioxides as endothelin antagonists |
09/19/2001 | CN1071325C Thiol derivatives with metallopeptidase inhibitory activity |
09/19/2001 | CN1071324C Process and intermediates for preparing 30(1-piperazinyl)-1,2-benzisothiazole |
09/18/2001 | US6291685 Reacting 1-(2-thienyl)allyl derivative in solvent medium containing base and carboxylic acid anhydride with carbon monoxide in presence of carbonylation catalyst to form ester compound; saponification to form 4-hydroxybenzothiophene |
09/18/2001 | US6291682 Pyrazol-4-ylbenzoyl derivatives and their use as herbicides |
09/18/2001 | US6291678 Process for the preparation of chiral keto-heterocycles of basic amino acids |
09/18/2001 | US6291672 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
09/18/2001 | US6291514 Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors |
09/18/2001 | US6291510 Small molecule inhibitors of rotamase enzyme activity |
09/18/2001 | US6291499 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
09/18/2001 | US6291491 Treatment of type ii diabetes and obesity; antidepressants; decrease gut motility. |
09/18/2001 | US6291486 Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals |
09/18/2001 | US6291481 Conditions related to a hampered or impaired gastric emptying and more generally to treat conditions related to a hampered or impaired gastrointestinal transit. |
09/18/2001 | US6291480 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
09/18/2001 | US6291477 Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia |
09/18/2001 | US6291476 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
09/18/2001 | US6291474 Bicyclic amine derivatives |
09/18/2001 | US6291467 Heteroaromatic derivatives |
09/18/2001 | US6291453 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
09/18/2001 | US6291432 (r)-n-(2-methylbenzyl)-3-((2s, 3s)-3-(n-(2-chromonecarbonyl)-l-asparaginyl)amino-2-hydroxy-4-phenylbutano yl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide can be given as a typical example of this compound. |
09/18/2001 | US6291400 Herbicidal compounds |
09/13/2001 | WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
09/13/2001 | WO2001066533A1 1,5-benzothiazepines and their use as hypolipidaemics |
09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
09/13/2001 | WO2001066520A1 Indole derivatives, process for preparation of the same and use thereof |
09/13/2001 | WO2001066099A2 Use of quinazoline derivatives as angiogenesis inhibitors |
09/13/2001 | US20010021775 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa |
09/13/2001 | US20010021716 Using agonist of nicotinergic acetylcholine receptors |
09/13/2001 | US20010021714 Compounds such as n-(4-bromo-3-methyl-5-isoxazolyl)-2-n-benzylbenzo(b)thiophene-3-sufonamide administered as endothelin peptide receptor antagonists |
09/13/2001 | DE19954228A1 New epothilone derivatives used for treating e.g. malignant melanoma, breast carcinoma, psoriasis, multiple sclerosis and arthritis |
09/13/2001 | CA2402174A1 Indole derivatives, process for preparation of the same and use thereof |
09/13/2001 | CA2401055A1 1,5-benzothiazepines and their use as hypolipidaemics |
09/12/2001 | EP1131321A2 Indole derivatives and their use as serotonin receptor ligands |
09/12/2001 | EP1131319A2 3- benz(ox/thi)azol-7-yl -1h-pyrimidine-2,4-diones |
09/12/2001 | EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes |
09/12/2001 | EP1131308A1 New piperazine and piperidine compounds |
09/12/2001 | EP1131306A2 Isoxazoline fibrinogen receptor antagonists |
09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
09/12/2001 | EP1131292A2 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
09/12/2001 | EP1032424B1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
09/12/2001 | EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
09/12/2001 | EP0882030B1 2,1,3-benzothia(oxa)diazole derivatives having an endothelin receptor antagonistic effect |
09/12/2001 | EP0832066B1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
09/12/2001 | CN1312809A N-substituted azabicycloheptane deriratives, production and use thereof |
09/12/2001 | CN1312807A Inhibitors of glycogen synthase kinase 3 |
09/12/2001 | CN1312806A Prodrugs of proton pump inhibitors |
09/12/2001 | CN1312803A Novel benzopykan or thiobenzopyran derivatives |
09/12/2001 | CN1312799A Bispiperidines as antithrombotic agents |
09/12/2001 | CN1070856C Thiazole derivative |
09/12/2001 | CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
09/11/2001 | US6288237 Plant protection. immunosuppression and/or be used to combat malignant tumours; they are particularily preferred as cytostatic agents. |
09/11/2001 | US6288236 Benzimidazole compounds containing a benzoxazole or benzothiazole ring, and compositions and methods of use containing the same |
09/11/2001 | US6288228 Triazine angiogenesis inhibitors |
09/11/2001 | US6288225 Substituted benzolactam compounds as substance P antagonists |
09/11/2001 | US6288095 Compounds |
09/11/2001 | US6288091 Compounds such as 2,2,2-trichloroethyl n-(4-(2-amino-4-thiazolyl)-phenyl)carbamate that inhibit the herpes helcase-primase enzyme complex |
09/11/2001 | US6288082 Compounds such as 6,7-diethoxy-4-(indan-5-ylamino) -quinoline-3-carbonitrile used as antineoplastic agents and in the treatment of polycycstic kidney disease |
09/11/2001 | US6288061 Imidazole derivatives |
09/11/2001 | US6288059 Acylated hetero-alicyclic derivatives |
09/11/2001 | US6288055 Analgesic agents |
09/11/2001 | CA2031570C Substituted cyclohexenes as central nervous system agents |
09/07/2001 | WO2001064675A1 Condensed thiazolamines and their use as neuropeptide y5 antagonists |
09/07/2001 | WO2001064674A1 2,4-disubstituted thiazolyl derivatives |
09/07/2001 | WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
09/07/2001 | WO2001064654A1 Pyrimidine compounds |
09/07/2001 | WO2001064653A1 Pyrimidine compounds |
09/07/2001 | WO2001064652A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias |
09/07/2001 | WO2001064650A2 Synthesis of epothilones, intermediates thereto and analogues thereof |
09/07/2001 | WO2001064644A1 Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides |
09/07/2001 | WO2001064637A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
09/07/2001 | WO2001064634A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
09/07/2001 | CA2401800A1 Synthesis of epothilones, intermediates thereto and analogues thereof |
09/07/2001 | CA2399704A1 Pyrimidine compounds |
09/07/2001 | CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
09/07/2001 | CA2339676A1 Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection |
09/06/2001 | US20010020034 Isothiazole derivatives useful as anticancer agents |
09/06/2001 | US20010020033 Selective factor xa inhibitors |
09/06/2001 | US20010020021 Metalloprotease inhibitor |
09/06/2001 | US20010020013 Polymerase inhibitors |
09/06/2001 | DE10010429A1 New 6-(4-sulfonamido-phenyl)-5-methyl-dihydropyridazinones, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia |
09/06/2001 | DE10010425A1 Medicaments for treating anemia, containing new or known 6-(4-(acylamino)-phenyl)-5-methyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity |
09/06/2001 | DE10010422A1 New 6-(4-carboxy-phenyl)-dihydropyridazinone esters or amides, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia |
09/05/2001 | EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors |
09/05/2001 | EP1130016A1 Thiocarbamic acid derivatives |
09/05/2001 | EP1130015A1 Pyridazinone derivatives |
09/05/2001 | EP1129084A2 Ppar gamma ligands |